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The mechanism of resistance to upper respiratory infections is poorly under- 
stood.  Agammaglobulinemic patients,  who are relieved in large part of lobar 
pneumonia,  septicemia, meningitis,  and  recurrent  urinary  tract infections  by 
gamma globulin, have persistent sinorespiratory tract infections, gastroenteritis, 
ileocolitis, and exudative enteropathy. This observation led us to consider the 
system  involved  in  immunologic  defense  of  the  mucous  surfaces  in  these 
patients. 
Tomasi and  coworkers  (1)  demonstrated  that IgA is the  predominant  im- 
mune globulin in saliva and colostrum despite the fact that IgA is a  minority 
component of the serum immunoglobulins. Tears (2), gastrointestinal secretions 
(2),  tracheobronchial  washings  (3),  and  nasal  secretions  (4)  have  since  been 
shown  to  contain  IgA as  the  predominant  immunoglobulin.  Tomasi  (5)  has 
presented evidence that the IgA in the saliva and colostrum are alike but differ 
from  serum  IgA  in  that  they  have  a  higher  sedimentation  coefficient,  llS 
rather than the 7S of serum IgA, and that they have an antigenic determinant 
not present in serum. 
These  observations raise certain important  questions.  Why is  IgA concen- 
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trated  in  mucous  secretions,  particularly as  compared  with  IgG,  the  major 
serum immunoglobulin and a  molecule of a  size comparable to serum IgA? Is 
the IgA of  secretions a  locally produced  unique  type  of  IgA, basically  dif- 
ferent from  serum  IgA; or is  there  a  mechanism  for selective  transport of a 
common  IgA molecule into  the  secretions which  is reflected in  the  immuno- 
chemistry  of  salivary  IgA? 
It is the purpose of this paper to report findings which shed light on these 
questions. We have observed that IgA can be selectively transported into saliva 
from  serum,  and  that  salivary IgA has  immunochemical  characteristics sug- 
gesting that it is composed of two separate immunochemical entities. It appears 
that salivary IgA differs from serum IgA only in that an additional protein is 
attached to the IgA molecule in its passage into the secretions. This additional 
protein can occur independently of IgA in agammaglobulinemic saliva and in 
saliva of many normal children. Although we have not directly demonstrated 
any transport role for this IgA-attached protein, we have found it operationally 
useful  to  call it  the  "transport  piece". 
Materials  and Methods 
Collection oi Samples.--Parofid fluid (referred to hereafter as "saUva") was chosen as the 
secretion for study, since it could be easily obtained in large volumes from all our subjects, 
and since prior studies of this secretion had been most complete.  Collections were made by 
means of a Curby cap (6), aided by stimulation with sour candy (Regal-Crown imported sour 
fruits, Murray Allen Imports, Inc., New York). Saliva samples were concentrated by negative 
pressure dialysis. Serum and saliva samples were tightly capped and kept frozen at --20°F 
until analyzed. 
Antiserum.--Antiserum against human IgA was prepared in goats using IgA isolated from 
colostrum.  In each instance the antiserum was absorbed with serum from a person  lacking 
IgA. This antiserum gave a single line when reacted in immunoelectrophoresis  and in gel dif- 
fusion against normal human serum.  It gave a  reaction of identity against colostrum  and 
normal saliva, i.e. a single line, with spurring over the serum IgA line (see Fig. 1). 
Immunochemical and Physicochemical Stadie~.--IgA levels were determined by a  modifi- 
cation of the method of Heremans as previously described (7) using radial diffusion in agar 
with incorporated antiserum. IgG and IgM quantitations were performed  with the Oudin 
tube technique (8). The antisem were prepared in rabbits by immunizing with several IgA 
myeloma proteins and with polyclonal IgM, prepared from  a pool of rheumatoid arthritis 
sera (7). Antiserum against human IgG, prepared in monkeys,  was obtained commercially 
(Immunology Incorporated, Glen Ellyn, Illinois, lot Cyn 34-1). Pure normal immunoglobulins 
prepared from serum as described  (7) were used as standards. The standard error with both 
methods was  -4-10%. Since the rate of diffusion in agar is dependent upon molecular  size, 
and since the standards were prepared with IgA purified from serum, all the apparent IgA 
values in saliva, as compared to serum IgA values, are falsely low, but the comparison among 
different saliva samples is valid. The sensitivity of the methods was: for IgA, 1 to 2 rag/100 
ml; for IgM, 2 to 5 rag/100 ml; and for IgG, 5 to 10 rag/100 ml. 
Double diffusion in gel was done by the method of Ouchterlony  (9). Immunoelectrophoresis 
was done by the micromethod  of Scheidegger (10). Salivary IgA was isolated by the method 
of Tomasi (5). The complement-fixing activity of isolated salivary IgA, aggregated by heating 
at 63°C for 30 rain, was tested by the method of Mayer (11).  1 
This test was kindly performed by Dr. Henry Gewurz. SOUTH~ COOPER~ WOLLHEIM~ ItONG~ AND  GOOD  617 
The IgA in normal saliva was reduced by the method of Fleishman et al. (12).  The saliva 
was  incubated  with  2-mercaptoethanol  0.2~  in  0.3 M  trihydroxy-methylamino-methane 
HC1 buffer,  pH 8.2,  at  room temperature  for  1 hr.  Iodoacetamide was added  in  equimolar 
amounts  and  the  mixture allowed to  stand  at  0°C for  1 hr.  The  saliva was  then dialyzed 
against sodium borate buffer,  pH 8.0. 
Infusion Studies.--Six agammaglobulinemic patients  were  selected  for infusion  studies. 
They ranged in age from 8 to 41 yr and were of both "acquired" and congenital  types. None 
had detectable IgA in serum or saliva. A total of 1 to 2 liters of fresh frozen  plasma was in- 
FIG.  1.  Antigenic relationship of serum and salivary IgA, illustrated by immune diffusion 
in gel. AS, antiserum against human colostral IgA prepared in goats; wells 1 and 4, serum from 
a  normal person; well 2,  saliva from a  normal person; and well 3, IgA isolated from saliva. 
All saliva samples in this and subsequent illustrations were parotid secretions and were con- 
centrated about X 25. Colostral and salivary IgA contain an antigenic determinant not present 
in serum IgA, as illustrated by the spurring of the salivary IgA line over the serum IgA line. 
This extra component is referred to in the text as "transport piece". 
fused into each of these patients  during an interval varying from 1 to 3 days.  Specimens of 
serum and saliva were collected before the infusions  and each day  following the last infusion 
for a period of 5 days. The serum specimens were analyzed to quantitate  the levels of IgA 
attained by the infusion,  and the saliva was analyzed to discover any IgA, IgG, or IgM trans- 
ferred from the infused plasma into the saliva. 
RESULTS 
When  IgA isolated from saliva  2 was  tested  by Ouchterlony  analysis  with an 
antiserum containing antibodies to colostral IgA, it was partially identical with 
serum  IgA  and  it  had  an  extra  antigenic  determinant  as  previously  demon- 
strated  by  Tomasi  (5)  (Fig.  1). 
Isolated  salivary IgA,  aggregated  by heat,  did not  fix complement.  Similar 
positive control  experiments  carried  out with heat-aggregated  IgG produced  a 
2 Saliva refers to parotid secretions throughout these results. 618  IGA  SYSTEM.  I 
sharp drop in the concentration of whole complement activity in the standard 
hemolytic assay. 
Studies  of Infusion  of A gammaglobulinemic  Patients  with Normal  Serum.  -- 
Table  I  presents  the  findings  of  the  infusion  studies.  Only  1 subject  (M.L.) 
attained a serum level of more than 100 rag%  IgA, and IgA appeared  in  this 
subject's saliva at the collections on the  1st,  3rd,  and 4th days after infusion. 
The  serum/saliva  ratio  was  approximately  1000/1.  There  was  no detectable 
IgM or IgG by Oudin tube  or Ouchterlony techniques in any of these saliva 
samples or samples from any of the other transfused patients, so the transport of 
IgA was selective.  Contamination of the samples with serum could not account 
for the presence of IgA since  this source would have supplied IgG and IgM as 
TABLE  I 
Infusion of A gammaglobulinemic Patients with Normal Plasma 
! 
Ag  ....  glob-  A  .....  t of  Peak .....  Apt  ........  AOoP~a.ra~ce 
ulinemie  of IgA in  lg  .. 
recipient  .....  infused  level of IgA  sahva  I  ian~a~igdat 
cc  mg  q{, 
Congenital sex-linked (M.L.) 
Congenital sex linked (T.G.) 
Congenital "sporadic" (J.K.) 
"Acquired" (L.L.) 
Congenital sex-linked (T. L.) 
1600 
1000 
1600 
1000 
2000 
150 
75 
88 
80 
90 
+++* 
+~ 
0§ 
0§ 
0§ 
* Indicates appearance of 0.1 mg of IgA per 100 ml saliva on 3 different days. 
{ The individual specimens collected on 5 successive posttransfusion days were pooled 
and concentrated X 225. 
§ Each sample of saliva was concentrated 50 to 100 times prior to analysis. 
well. Because of difficulty in obtaining cooperation from this child,  only small 
amounts of saliva could be obtained, and extensive physicochemical analysis of 
the secreted IgA could not be carried out.  Fig. 2 compares immunoelectropho- 
retic patterns of norm al saliva, and the saliva of this agammaglobulinemic  patient 
before and after infusion. The antiserum used was specific for sermn IgA. The 
IgA which appeared in the saliva after infusion produced an immunoelectropho- 
retic pattern similar to the normal salivary IgA. 
Another  agammaglobulinenric patient  showed  a  trace  of IgA in  the  saliva 
following infusion of normal  serum.  Although an  IgA line  was  observed in  a 
pooled and concentrated posttransfusion specimen, the IgA level was too low to 
be accurately measured; still  this sample contained no detectable IgG or IgM 
and,  as in the prior study, supported the concept of selective transport of IgA 
into  the  parotid  secretions. 
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An  untreated  agammaglobulinemic  patient's  saliva,  when  reacted  in  agar 
diffusion with antibody against purified colostral IgA, gave a distinct precipitin 
band. By contrast, no precipitin line formed when the same saliva specimen was 
reacted  with  antibody  against  purified  serum  IgA.  This  precipitin  band  was 
subsequently  shown  to  give a  reaction  of partial  identity  with  the  precipitin 
Fio.  2.  Immunoelectrophoresis  of saliva  from  a  normal  person  and  from  an  agamma- 
globulinemic patient before and after infusion with normal plasma. Wells 1 and 3 are empty; 
well 2, saliva from a normal person; wells 4 and 6, saliva of M. L. before plasma  infusions; 
and well 5, saliva of M. L. after plasma infusion. All the troughs contain serum from rabbits 
hyperimmunized with  purified IgA myeloma globulin. The cathode is at the left. After in- 
travenous infusion of fresh whole plasma (1600 ml) IgA appeared in the saliva collected from 
this agammaglobulinemic patient on 3 successive days. 
band formed when the antiserum against colostral IgA was reacted with normal 
salivary IgA, but complete  nonidentity to the reaction produced with  normal 
serum  IgA (Fig.  3).  This  is  the antigenic  determinant  originally described by 
Tomasi  et  al.  (5) 3 as  attached  to  salivary  and  colostral  IgA globulin,  and  is 
referred  to as the "transport  piece" in this and previous reports  (13,  14).  This 
3  This relationship was confirmed with antiserum kindly sent to us by Dr. Tomasi. 620  IGA  SYSTEM.  I 
FIG.  3.  Antigenic relationship of transport piece to IgA, illustrated by immune diffusion 
in gel.  AS, antiserum against human colostral IgA prepared in goats; well  1,  saliva from a 
normal person; well 2, saliva from an agammaglobulinemic person; and well 3, serum from a 
normal  person.  The  transport piece,  occurring independently in  the agammaglobulinemic 
saliva,  is partially identical to normal salivary IgA but nonidentical to serum IgA. Note also 
the character of the normal salivary IgA line. Its curve indicates that it is composed of larger 
molecules than is the serum IgA globulin. 
FIG. 4.  Dissociation of  the  salivary  IgA  from  the transport piece by  mercaptoethanol 
reduction, shown by  immune diffusion  in  gel.  AS,  antiserum against human  colostral IgA 
prepared in goats; well  l, saliva from a normal person; well 2, serum from a normal person; 
well 3, saliva from a normal person reduced with 2-mercaptoethanol; and well 4, saliva from 
an agammag]obulinemic patient. After incubation with 0A M mercaptoethanol, salivary IgA 
is dissociated into two components, one antigenically identical to serum IgA aml the other 
antigenically identical  to the  free  transport  piece as it  occurs  in  the  saliva of  agamma- 
globulinemic  patients. SOUTH,  COOPER,  WOLLHEIM,  I-IONG~ AND  GOOD  621 
substance  has  subsequently  been  demonstrated  in  the  saliva  of  each  of  18 
agammaglobulinemic patients studied to date,  2 patients with ataxia-telangiec- 
tasia  who lacked  IgA in serum  and  saliva,  a  healthy adult  with  the  anomaly 
described by Rockey, Hanson, Heremans,  and Kunkel  (15)  who had no IgA in 
serum or saliva  4 and a  12-hr-old infant before the first feeding, with no demon- 
strable  IgA in serum or saliva.  In more than  100 determinations  we have not 
found any saliva sample which lacks the transport piece, although concentrating 
the saliva sample is usually necessary for its demonstration. 
FIo.  5.  Occurrence of free transport  piece in the parotid  secretions of a child, illustrated 
by immune diffusion in gel. AS, antiserum  against  human co/ostral IgA prepared  in goats; 
wells  1 and 4, saliva of a  child; well 2, saliva of an agammaglobulinemic patient; well 3, 
saliva of a normal adult; and well 5, serum of a normal adult. The child's saliva contains free 
transport  piece, represented  by  the  bands  nearest  the  center  well, which is  antigenically 
identical to the transport  piece in the agammaglobulinemic patient's saliva. Newborn babies, 
although they have no IgA in saliva, have transport  piece. 
In the reduced and alkylated form the normal salivary IgA is dissociated  to 
form two distinct  bands  when reacted  against  anticolostral  IgA, as  had  been 
demonstrated by Tomasi and associates (5).  One of these lines is identical with 
the serum  IgA line,  and the other is identical  with  the  transport  piece line in 
agammaglobulinemic  saliva  (Fig.  4).  The  transport  piece has also been found 
"free" in normal saliva, most frequently in  children's saliva  (Fig. 5). 
Fig.  6  compares  the  immunoelectrophoretic  patterns  of  the  agammaglobu- 
linemic saliva and normal saliva.  The free transport  piece is shown  to migrate 
in the gamma1 region. The transport piece determinant is demonstrated in both 
normal saliva and agammaglobulinemic saliva,  but the IgA determinant  in the 
normal saliva only. 
4 Patient of Dr. Douglas Heiner, Salt Lake City. 622  IGA  SYSTEM.  I 
FIG. 6.  Immunoelectrophoretic properties of free transport piece.  Well  i, saliva from an 
agammaglobulinemic patient; well 2, saliva from a normal person; trough A, antiserum against 
human colostral IgA prepared  in goats;  trough B,  the same antiserum absorbed with lyo- 
philized normal serum; and trough C, the same antiserum absorbed with lyophilized agamma- 
globulinemic saliva. The  cathode  is  at  the  left. The  transport  piece,  a  gammal-migrating 
protein, is attached to the IgA in normal saliva but occurs independently in the agamma- 
globulinemic patient's saliva. Serum IgA, not illustrated here, has a similar migration. 
DISCUSSION 
These observations are of interest from several points of view. First, we have 
been able to confirm and extend the discoveries of Tomasi and associates which 
show  clearly that  IgA in  the  saliva and  colostrum  is  immunochemieally dif- 
ferent from IgA in  the  serum.  The  saliwtry IgA can  be dissociated  into  two 
antigenically distinct components by treatment with 2-mercaptoethanol. One of 
the components appears immunochemicallv identical to serum IgA. The other 
component is immunochemically identical  to a  protein, the  "transport piece", 
found in the saliva of patients completely lacking both serum and salivary IgA. SOUTII~ COOPER, WOLT.lqq~.1]~,  HONO, AND GOOD  623 
Thus far the IgA component has been found only in combination with the 
transport piece component in the saliva of children  and adults. However,  the 
transport piece is present also in an unbound form in the saliva of most children 
and some adults. It may be that transport piece is present in free form in young 
children's saliva  because  of the  gradual increase  of IgA production during 
childhood. The IgA serum levels rise slowly with age (16--18) and reach average 
adult levels around puberty (7). It could well be that children have an excess 
of transport piece because their formation of the IgA component of the salivary 
IgA is relatively deficient when compared to that of older children and adults. 
Perhaps of greatest interest in these studies is the finding that patients with 
agammaglobulinemia and ataxia-telangiectasia who do not synthesize the serum 
IgA nonetheless possess the transport piece in saliva. Thus, from these patients 
the transport piece can be isolated and studied without need to consider its 
immediate relationship to the serum IgA determinant. Further, agammaglob- 
ulinemic patients, laddng a plasma cell system for synthesizing IgA (19) as 
well as the other immunoglobulins, present a strong argument for the concept 
that the transport piece is formed in cells different from those responsible for 
production of the IgA and the other immunoglobulins.  This is  of particular 
interest  because  the  transport  piece  travels  electrophoretically  as  gammal 
globulin. 
Immunoh/stochemical studies previously carried  out on salivary glands are 
consonant with these findings,  since  Tomasi and associates  (5)  showed  that 
the serum IgA component could be identified by the fluorescent antibody tech- 
nique in the plasma cells of the salivary gland,  whereas  the additional com- 
ponent immunochemically related to salivary IgA but not to serum IgA was 
detectable only in the acinar ceils adjacent to collecting ducts (perhaps  the 
ductal epithelial  cells) of the salivary gland. 
In these  studies we have further shown that IgA can be specifically trans- 
ported  into  saliva  of  patients  with  agammaglobulinemia,  an  observation 
which can be taken as support for the concept that the IgA component in saliva 
is the same as that in serum,  and is derived  also from the plasma ceils. The 
transport of IgA from serum to saliva in man is not surprising, since antibodies 
administered intravenously had been shown to appear in the secretions of the 
mouse (20), rabbit (21), and guinea pig (22), although these antibodies were not 
known to be of the Igh type. In our studies it is particularly important to 
emphasize that the transport of IgA into saliva occurred in the absence of trans- 
port of the other two immunoglobulins, IgG and IgM, even though the latter 
two  components  were  present  in  the  serum  in  higher  concentrations after 
plasma  infusions  into  agammaglobulinenfic  patients  than  was  IgA.  These 
observations  suggest the existence of a specific transport mechanism for IgA. 
Such a transport mechanism might, indeed, involve  the transport piece, with 
production of the transport piece by the epithelial  cells, reception  of the IgA 624  IoA $¥STEH. I 
from the plasma ceils by specific combination with the transport  piece,  and 
subsequent secretion of the combined molecule into the lumen of the salivary 
duct. 
The  infusion  studies  in  the  agammaglobulinemic  patients  stress  another 
important  point,  namely  that  high  concentrations  of IgA  are  necessary  to 
achieve such transport. Indeed, in our experiments transport of IgA from serum 
to saliva was observed in only 2 of 5 patients: in pooled posttransfusion samples 
of 1 child, but in 3 of 5 posttransfusion samples in the patient with the highest 
serum  IgA  level.  In  keeping  with  these  observations,  other  investigators 
(5,  23)  failed to demonstrate  this  transportation  after infusion of relatively 
small  amounts of Ira-labeled IgA. Is the need for high concentrations at the 
epithelial cell surface the reason for such large numbers of plasma cells in the 
lamina propria of the gut, and for their presence in the interstitial tissue of the 
salivary  glands  and  mammary  glands?  Local production  of IgA might  be 
expected to deliver high concentrations of this globulin directly to the epithelial 
cells for subsequent combination with  transport  piece and  delivery into  the 
secretions.  In this regard, it is of interest that Crabb~ (24) has shown that an 
average of 80 % of the plasma cells of the intestinal lamina propria are IgA- 
producing  cells,  a  much higher  proportion  of IgA producers than  is seen in 
lymph nodes and spleen (25, 26). ttochwald et al. (27) showed that C14-1abeled 
amino  acids are incorporated  directly into IgA in  salivary gland  as well as 
mammary gland tissue cultures. Evidence of local specific antibody production 
in many species has been reviewed by Pierce  (28).  This evidence, including 
the observations of antibody appearing earlier in secretions than in serum, or in 
higher titer, or occasionally exclusively in secretions,  speaks strongly for local 
antibody production. 
Heat aggregated IgA and IgA antibodies from serum do not utilize comple- 
ment  (29--31). In our study, aggregated salivary IgA also failed to show any 
complement-fixing  activity. Since saliva and intestinal contents are, by pH and 
salt  concentration,  anticomplementary,  a  complement-requiring  antibody 
system would be of no biological  advantage in these fluids. The IgA group of 
antibodies  function  either  alone  or  with  the  aid  of biologically  active  sub- 
stances other than complement. The transport piece might furnish such aid, or 
might serve either to stabilize  the IgA molecule or in some other way make it 
better able to act in the milieu of the mucous surfaces. 
The experiments of nature represented by patients lacking IgA: the agamma- 
globulinemics  treated only with IgG, and ataxia-telangiectasia  patients,  sup- 
port the concept that this system has biologic  significance.  The rare healthy 
persons with no IgA in serum or secretions seem to have been able to compen- 
sate by delivery of both IgG and IgM into the secretions, as reported by Rockey 
and associates (15) and Tomasi and associates (5), and as found in 1 person by SOUTH, COOPER,  WOLLHEIM,  HONG, AND GOOD  625 
us.  5 These persons may present a  key to greater understanding of  the whole 
local protective process. 
SUM'MARY 
1.  Five patients with congenital or acquired agammaglobulinemia, lacking 
detectable IgA in serum or saliva, were transfused with 1 to 2 liters of normal 
plasma. In 2 of these patients IgA was demonstrated in parotid saliva collected 
after transfusion, but in none of the 5 was salivary IgG or IgM found. This 
observation indicates the selective transport of IgA into saliva. 
2.  The  observation  by  others  of  an  immunochemical difference between 
serum  and  salivary IgA globulin was  confirmed. In contrast to serum IgA, 
salivary IgA is attached to a protein having antigenicity which migrates as a 
gamma1 globulin. We have termed this protein component "transport piece". 
3. The transport piece has been found in an unbound form in the saliva of 
persons completely lacking IgA: agammaglobulinemic patients, ataxia-telangi- 
ectasia patients,  a  healthy person lacking IgA,  and a  newborn infant.  Free 
transport piece still occurs in the normal child's saliva after IgA production 
begins. By adulthood there is usually no free transport piece in the saliva. 
4. Heat-aggregated salivary IgA, like heat-aggregated serum IgA, does not fix 
complement. 
5. Our findings offer support for the view that there is a distinct local antibody 
system for the protection of the mucous surfaces. 
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